These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37908176)

  • 1. The efficacy and adverse events of arsenic trioxide for the patients with myelodysplastic syndrome: a systematic review and component network meta-analysis.
    Huang X; Liu Y; Liu R; Zou X; Yang H
    Hematology; 2023 Dec; 28(1):2274149. PubMed ID: 37908176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
    Lu J; Jin J; Xu WL
    Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].
    Xu SN; Chen JP; Liu JP; Xia Y
    Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of thalidomide and arsenic trioxide is effective and well tolerated in patients with myelodysplastic syndromes.
    Wei W; Zhou F; Zhang Y; Guo L; Shi H; Hou J
    Leuk Res; 2012 Jun; 36(6):715-9. PubMed ID: 22277680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo].
    Lu J; Jin J
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes.
    Schiller GJ; Slack J; Hainsworth JD; Mason J; Saleh M; Rizzieri D; Douer D; List AF
    J Clin Oncol; 2006 Jun; 24(16):2456-64. PubMed ID: 16651647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide for the treatment of myelodysplastic syndromes.
    Vey N
    Expert Opin Pharmacother; 2004 Mar; 5(3):613-21. PubMed ID: 15013929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of all-trans retinoic acid-linked arsenic trioxide treatment for acute promyelocytic leukemia.
    Chen L; Wang J; Hu X; Xu X
    Hematology; 2014 Jun; 19(4):202-7. PubMed ID: 24074286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decitabine shows synergistic effects with arsenic trioxide against myelodysplastic syndrome cells via endoplasmic reticulum stress-related apoptosis.
    Huang L; Liu Z; Jiang H; Li L; Fu R
    J Investig Med; 2019 Oct; 67(7):1067-1075. PubMed ID: 30898879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.
    Sekeres MA; Maciejewski JP; Erba HP; Afable M; Englehaupt R; Sobecks R; Advani A; Seel S; Chan J; Kalaycio ME
    Cancer; 2011 Mar; 117(6):1253-61. PubMed ID: 20960521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide, thalidomide and retinoid acid combination therapy in higher risk myelodysplastic syndrome patients.
    Zheng WL; Zhang GS; Xu YX; Shen JK; Dai CW; Pei MF
    Leuk Res; 2008 Feb; 32(2):251-4. PubMed ID: 17920679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity.
    Wu X; Hu Z; Nizzero S; Zhang G; Ramirez MR; Shi C; Zhou J; Ferrari M; Shen H
    J Control Release; 2017 Dec; 268():92-101. PubMed ID: 29042320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug.
    Bonati A; Rizzoli V; Lunghi P
    Curr Pharm Biotechnol; 2006 Dec; 7(6):397-405. PubMed ID: 17168655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide as a treatment for myelodysplastic syndrome.
    Sekeres MA
    Curr Hematol Malig Rep; 2006 Mar; 1(1):34-8. PubMed ID: 20425329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: a meta-analysis.
    Wang H; Chen XY; Wang BS; Rong ZX; Qi H; Chen HZ
    Leuk Res; 2011 Sep; 35(9):1170-7. PubMed ID: 21774985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells.
    Zeng Y; Weng G; Fan J; Li Z; Wu J; Li Y; Zheng R; Xia P; Guo K
    Oncol Rep; 2016 Sep; 36(3):1233-42. PubMed ID: 27430728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
    Vey N; Bosly A; Guerci A; Feremans W; Dombret H; Dreyfus F; Bowen D; Burnett A; Dennis M; Ribrag V; Casadevall N; Legros L; Fenaux P
    J Clin Oncol; 2006 Jun; 24(16):2465-71. PubMed ID: 16651646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute lung injury induced by arsenic trioxide in a patient with refractory myelodysplastic syndrome.
    Hassaballa HA; Lateef OB; Silver MR; Balk RA
    J Crit Care; 2005 Mar; 20(1):111-3. PubMed ID: 16015525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience.
    Wang H; Hao L; Wang X; Li J; Wu Q; Bian S
    Int J Hematol; 2010 Jun; 91(5):820-5. PubMed ID: 20461563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The safety and efficacy of low dose subcutaneous decitabine combined with arsenic trioxide in patients with inermediate or higer-risk myelodysplastic syndrome].
    Ai H; Wei XD; Yin QS; Mi RH; Chen L; Wang Q; Song YP
    Zhonghua Nei Ke Za Zhi; 2019 Dec; 58(12):908-910. PubMed ID: 31775455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.